Hereditary Angioedema Types I and II: 17 Clinical Trials, Page 1 of 2

1 2

Hide Studies Not Open or Pending

8

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Condition(s):Hereditary Angioedema; Hereditary Angioedema Type I; Hereditary Angioedema Type II; Hereditary Angioedema Types I and II; Hereditary Angioedema Attack; Hereditary Angioedema With C1 Esterase Inhibitor Deficiency; Hereditary Angioedema – Type 1; Hereditary Angioedema – Type 2; C1 Esterase Inhibitor Deficiency; C1 Inhibitor DeficiencyLast Updated:August 16, 2021Recruiting

1 2

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.